ZALEVSKY JONATHAN (Chief R&D Officer) sold 0.8% of their position (180.00 shares) of NEKTAR THERAPEUTICS on the open market
Open‑market sale worth $13.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/20/2026ACC: 0001193125-26-061886
Officer· Chief R&D Officer
Since Oct 2019
-180.00
Net shares
Net seller
$13.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
180.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−180.00
Price / share
$73.00
Trade value
$13.14K
% of position
0.8%
2/18/2026
21.35K→21.17K
Total
Net shares
−180.00
Net value
-$13.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/18/2026 | S · Sale | −180.00 | $73.00 | $13.14K | 0.8% | 21.35K | 21.17K |
| Total | −180.00 | -$13.14K | ||||||
Derivative Transactions0
No derivative transactions reported